| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 8418.280273 | height | CFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 11359.41699 | height | CFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 13048.41016 | height | CFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 22550.99414 | height | CFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 26658.66602 | height | cele_HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 32298.16602 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 33745.74609 | height | Cele_pro |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 39633.94141 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 53351.89453 | height | Cele_pro |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 60191.24219 | height | Cele_pro |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 62160.65234 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 68498.3125 | height | cele_HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 73676.63281 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 98771.75781 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 99820.14063 | height | HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 106580.25 | height | cele_HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 107831.4063 | height | cele_HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 142038.8125 | height | cele_HFD |
| Reversed phase NEGATIVE ION MODE | 3-O-(Galb)-(25R)-12-oxo-5alpha-spirostan-3beta-ol | 172510.0625 | height | HFD |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|